#VisualAbstract: Ticagrelor monotherapy reduces bleeding risk following percutaneous coronary intervention
1. Clinically relevant bleeding was significantly lower with ticagrelor monotherapy than in the ticagrelor plus aspirin group. 2. Major cardiovascular ...